Cell therapy weekly: US FDA approves new cell-based gene therapy for patients with B-cell lymphoma

Written by RegMedNet

This week: the US FDA has approved a cell-based gene therapy for adult patients with certain types of B-cell lymphoma, positive data has been reported in a Phase II trial for an ‘off-the-shelf’ allogeneic cell-based therapy for non-small cell lung cancer, no safety concerns have been flagged for a Phase I/II trial of a gene therapy for Huntington’s disease, and AbbVie has entered into a collaboration and license agreement with Caribou Biosciences for the research and development of CAR-T cell therapeutics. The news headlines: US FDA approves new cell-based gene therapy for patients with B-cell lymphoma Positive Phase II data...

To view this content, please register now for access

It's completely free